Abstract
Neurocognitive effects of multiple sclerosis are increasingly recognized in both adult and pediatric MS populations. In addition, secondary mood disorders related to being diagnosed with a neurodegenerative condition, to especially include depression, are not uncommon and can negatively affect long-term quality of life outcomes. Primary psychiatric manifestations of multiple sclerosis are unusual, and the underlying demyelinating disease may not be discovered until more typical attack symptoms occur. This chapter presents pediatric multiple sclerosis with an initial psychiatric presentation. A 14-year-old boy initially presented with symptoms of depression, paranoia, and new-onset migraine. He required inpatient psychiatric hospitalization for worsening of these symptoms as well as new visual and auditory hallucinations. During the hospitalization he developed facial numbness, visual complaints, and leg weakness. He was ultimately diagnosed with multiple sclerosis (MS) which responded to treatment with glatiramer acetate and psycho-pharmacotherapy. Aspects of primary psychiatric disease in multiple sclerosis and its treatment will be reviewed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Haussleiter IS, Brüne M, Juckel G. Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment. Ther Adv Neurol Disord. 2009;2(1):13–29.
Fermo SL, Barone R, Patti F, Laisa P, Cavellaro TL, Nicoletti A, Zappia M. Outcome of psychiatric symptoms presenting at onset of multiple sclerosis: a retrospective study. Mult Scler. 2010;16(6):742–8.
Sullivan MJL, Weinshenker B, Mikail S, Edgley K. Depression before and after diagnosis of multiple sclerosis. Mult Scler. 1995;1(2):104–8.
Zarei M, Chandran S, Compston A, Hodges J. Cognitive presentation of multiple sclerosis: evidence for a cortical variant. J Neurol Neurosurg Psychiatry. 2003;74(7):872–7.
Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, Clover L, Parkinson A, Bien CG, Omer S, Lang B, Rossor MN, Palace J. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127(3):701–12.
Drozdowicz LB, Bostwick JM. Psychiatric adverse effects of pediatric corticosteroid use. Mayo Clin Proc. 2014;89(6):817–34.
Minden SL, Feinstein A, Kalb RC, Miller D, Patten SB, Bever C, Schiffer RB, Gronseth GS, Narayanaswami P. Evidenced-based guideline: assessment and management of psychiatric disorders in individuals with MS. Neurology. 2014;82(2):174–81.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Tomko, S., Lotze, T.E. (2017). Pediatric Multiple Sclerosis Manifesting with Primary Psychiatric Symptoms. In: Waubant, E., Lotze, T. (eds) Pediatric Demyelinating Diseases of the Central Nervous System and Their Mimics. Springer, Cham. https://doi.org/10.1007/978-3-319-61407-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-61407-6_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61405-2
Online ISBN: 978-3-319-61407-6
eBook Packages: MedicineMedicine (R0)